Stable malaria incidence despite scaling up control strategies in a malaria vaccine-testing site in Mali.

Published online

Journal Article

BACKGROUND: The recent decline in malaria incidence in many African countries has been attributed to the provision of prompt and effective anti-malarial treatment using artemisinin-based combination therapy (ACT) and to the widespread distribution of long-lasting, insecticide-treated bed nets (LLINs). At a malaria vaccine-testing site in Bandiagara, Mali, ACT was introduced in 2004, and LLINs have been distributed free of charge since 2007 to infants after they complete the Expanded Programme of Immunization (EPI) schedule and to pregnant women receiving antenatal care. These strategies may have an impact on malaria incidence. METHODS: To document malaria incidence, a cohort of 400 children aged 0 to 14 years was followed for three to four years up to July 2013. Monthly cross-sectional surveys were done to measure the prevalence of malaria infection and anaemia. Clinical disease was measured both actively and passively through continuous availability of primary medical care. Measured outcomes included asymptomatic Plasmodium infection, anaemia and clinical malaria episodes. RESULTS: The incidence rate of clinical malaria varied significantly from June 2009 to July 2013 without a clear downward trend. A sharp seasonality in malaria illness incidence was observed with higher clinical malaria incidence rates during the rainy season. Parasite and anaemia point prevalence also showed seasonal variation with much higher prevalence rates during rainy seasons compared to dry seasons. CONCLUSIONS: Despite the scaling up of malaria prevention and treatment, including the widespread use of bed nets, better diagnosis and wider availability of ACT, malaria incidence did not decrease in Bandiagara during the study period.

Full Text

Duke Authors

Cited Authors

  • Coulibaly, D; Travassos, MA; Kone, AK; Tolo, Y; Laurens, MB; Traore, K; Diarra, I; Niangaly, A; Daou, M; Dembele, A; Sissoko, M; Guindo, B; Douyon, R; Guindo, A; Kouriba, B; Sissoko, MS; Sagara, I; Plowe, CV; Doumbo, OK; Thera, MA

Published Date

  • September 19, 2014

Published In

Volume / Issue

  • 13 /

Start / End Page

  • 374 -

PubMed ID

  • 25238721

Pubmed Central ID

  • 25238721

Electronic International Standard Serial Number (EISSN)

  • 1475-2875

Digital Object Identifier (DOI)

  • 10.1186/1475-2875-13-374


  • eng

Conference Location

  • England